Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Hormonal Regulation of Blood Pressure

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Cellular Adaptation II: Hypertrophy

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...

Hormonal Regulation

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.

Antihypertensive Drugs: Potassium-Sparing Diuretics

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Single-Cell dissection of fibrodysplasia ossificans progressiva identifies SPP1 as a mediator of macrophage-fibroadipogenic progenitors crosstalk.

Cellular and molecular life sciences : CMLS·2026

Same author

Deciphering Silence: Functional Studies of GCK Synonymous and Nonsense Variants and Their Importance in Understanding Diabetes.

Genes·2026

Same author

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.

Frontiers in pharmacology·2025

Same author

Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant.

PloS one·2025

Same author

In silico, in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators.

British journal of pharmacology·2025

Same author

Chromosomal Deletion Involving ANKRD26 Leads to Expression of a Fusion Protein Responsible for ANKRD26-Related Thrombocytopenia.

International journal of molecular sciences·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Isolation of Atrial Myocytes from Adult Mice

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

C-type natriuretic peptide and overgrowth.

Renata Bocciardi¹, Roberto Ravazzolo

¹Laboratory of Molecular Genetics, G. Gaslini Institute, Genova, Italy. bocciardi@unige.it

Endocrine Development

|March 19, 2009

Summary

Overexpression of C-type natriuretic peptide (CNP) due to gene translocation causes skeletal anomalies and overgrowth. This finding links NPPC gene regulation to human skeletal development and associated overgrowth phenotypes.

Area of Science:

Endocrinology
Genetics
Skeletal Biology

Background:

Natriuretic peptides, including C-type natriuretic peptide (CNP), are crucial signaling molecules.
CNP plays a vital role in endochondral ossification and chondrocyte maturation, regulating cell proliferation and differentiation.
The NPPC gene, encoding CNP, is located on human chromosome 2, with no prior reported mutations.

Purpose of the Study:

To investigate the genetic basis of a rare skeletal overgrowth phenotype.
To explore the link between NPPC gene regulation and observed clinical manifestations.
To understand the impact of CNP overproduction on skeletal development.

Main Methods:

Clinical case study analysis of patients with skeletal anomalies and overgrowth.

More Related Videos

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Published on: May 16, 2022

Related Experiment Videos

Last Updated: Jun 24, 2026

Isolation of Atrial Myocytes from Adult Mice

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Published on: May 16, 2022

Genetic analysis to identify chromosomal abnormalities.

Molecular investigation of NPPC gene expression and CNP plasma concentrations.

Main Results:

Three patients presented with a consistent phenotype of skeletal anomalies and overgrowth.
A balanced translocation involving chromosome 2 was identified in all affected individuals.
This translocation led to NPPC gene overexpression and elevated plasma CNP levels.
Transcriptional dysregulation, caused by separation from regulatory elements, was linked to CNP overproduction.

Conclusions:

Balanced translocations affecting chromosome 2 can disrupt NPPC gene regulation, leading to CNP overproduction.
CNP overproduction is correlated with the observed skeletal overgrowth phenotype.
This study highlights the critical role of NPPC gene regulation in human skeletal development and disease.